MEREO BIOPHARMA GROUP PL-ADR (MREO) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:MREO • US5894921072

0.41 USD
+0.02 (+5.67%)
At close: Feb 10, 2026
0.4055 USD
0 (-1.1%)
After Hours: 2/10/2026, 8:24:29 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MREO revenue by date.MREO revenue by date.
50.14M
-100.00%
10M
-100.00%
530.4K34.28M
6,363.05%
47.528M
38.65%
159.56M
235.72%
44.477M
-72.13%
105.2M
136.53%
173.12M
64.56%
245.35M
41.72%
347.71M
41.72%
EBITDA
YoY % growth
MREO ebitda by date.MREO ebitda by date.
-27.905M
39.49%
-52.781M
-89.15%
-27.355M
48.17%
-53.026M
-69.17%
-73.233M
-58.25%
-26.145M
64.30%
9.856M
137.70%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MREO ebit by date.MREO ebit by date.
-28.788M
40.24%
-53.677M
-86.46%
-28.416M
47.06%
-43.817M
-66.68%
-49.161M
-3.79%
-28.301M
42.43%
-27.287M
3.58%
46.196M
269.30%
-44.462M
-196.25%
1.803M
104.06%
58.979M
3,171.16%
119.53M
102.67%
211.43M
76.88%
Operating Margin
MREO operating margin by date.MREO operating margin by date.
-57.42%N/A-284.16%N/A-9,268.61%-82.56%-57.41%28.95%-99.97%1.71%34.07%48.72%60.81%
EPS
YoY % growth
MREO eps by date.MREO eps by date.
N/A
91.18%
N/A
-47.54%
N/A
38.67%
-0.06
-8.58%
-0.06
-3.75%
-0.03
44.45%
-0.04
-20.01%
0.05
211.50%
-0.05
-201.35%
0.00
100.00%
0.060.12
108.48%
0.20
73.07%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.01
73.76%
0.00
97.96%
-0.01
93.88%
-0.01
-22.40%
-0.01
61.12%
Revenue
Q2Q % growth
8.925M4.335M
767.00%
40.341M
EBITDA
Q2Q % growth
39.78M
380.40%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-11.843M
22.47%
-1.646M
85.04%
-6.369M
39.34%
-11.028M
-10.12%
5.206M
143.96%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.01
90.00%
-0.020.0159.64%
Q2 2025
Q2Q % growth
-0.10 -0.02-0.08-499.63%
Q1 2025
Q2Q % growth
-0.10 -0.01-0.09-1,246.69%
Q4 2024
Q2Q % growth
-0.05
-15,215.56%
-0.01-0.04-240.11%
Q3 2024
Q2Q % growth
-0.10 -0.02-0.08-459.58%
Q2 2024
Q2Q % growth
-0.10
-39,115.69%
-0.01-0.09-877.46%
MREO Yearly EPS VS EstimatesMREO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2031 2032 2033 0 0.2 -0.2 -0.4 -0.6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
11.9M-11.9M-100.00%
Q1 2025
Q2Q % growth
19.063M-19.063M-100.00%
Q4 2024
Q2Q % growth

-100.00%
%
Q2 2024
Q2Q % growth

-100.00%
%
Q4 2023
Q2Q % growth
10M 37.23M-27.23M-73.14%
Q2 2022
Q2Q % growth

-100.00%
%
MREO Yearly Revenue VS EstimatesMREO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2023 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-92.8% -164.3% 0% 5.26%
Revenue-100% -100% -96.92% -98.13%